Two new molecular entities treat hypertension and COPD
June 15th 2011FDA has approved azilsartan medoxomil 40-mg and 80-mg tablets for the treatment of hypertension, either alone or in combination with other antihypertensive agents. FDA has also approved roflumilast as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations (not the relief of acute bronchospasm).
Drug Topics releases top 200 branded and generic drug lists
June 14th 2011Despite a drop in the number of prescriptions written for the top 10 branded drugs in 2010 compared with 2009, there were gains in terms of retail dollars among most of the manufacturers of the top 10 products, according to the Drug Topics top 200 branded drugs lists.
Novo Nordisk pays fine for off-label promotion of hemostasis drug
June 14th 2011The battle against illegal drug promotion continues. The latest culprit is Novo Nordisk, which agreed to pay $25 million to settle civil liabilities over off-label promotion for its hemostasis drug NovoSeven (recombinant factor VIIa ) on June 10.
Study finds unexpectedly high risk of hypertension for young adults
June 7th 2011Nearly 20% of young adults in the United States may have high blood pressure, according to the National Longitudinal Study of Adolescent Health, an analysis sponsored by the National Institutes of Health and published online in Epidemiology.
TV-based patient education improves engagement, quality of care
May 26th 2011Integrated television-based technology can help hospitals meet the patient-centeredness requirements of federal reform initiatives, stated a recent white paper released by LodgeNet Healthcare, a provider of media and connectivity solutions for hospitals.
HIV infection risk for uninfected sex partners reduced by early ART
May 26th 2011Early commencement of oral antiretroviral therapy by men and women infected with HIV substantially reduced the risk that they would transmit the virus to their uninfected sexual partners, according to findings from a large multinational clinical study conducted by the HIV Prevention Trials Network.
Community pharmacists rally on Capitol Hill
May 24th 2011The National Community Pharmacists Association Conference taking place May 23 to May 25 in Washington, D.C., at the Hyatt Regency on Capitol Hill is focusing on how the expert medication counseling and new, nontraditional services provided by local pharmacists can help reduce costs and improve patient outcomes.